Latest in Lilly Beats Earnings
Sort by
436 items
-
Lilly’s Mounjaro and Zepbound contribute to big revenue boost, drugmaker says
Eli Lilly has “tremendous momentum” entering 2025, CEO David A. Ricks said Thursday.MarketWatch - 4h -
Fiserv shares rally to record on earnings beat, bullish revenue outlook
Shares of payments company Fiserv rose to a record on Wednesday after reporting better-than-expected earnings.CNBC - 20h -
Ford beats earnings expectations but forecasts tougher year ahead
Ford Motor beat Wall Street's top- and bottom-line expectations for the fourth quarter but forecast a tougher year ahead for the company.CNBC - 21h -
Chipotle earnings beat estimates, but stock falls on weak same-store sales forecast
Chipotle earnings beat estimates as restaurant traffic rises again.CNBC - 1d -
PepsiCo earnings beat estimates, but demand for drinks and snacks drops in North America
PepsiCo's earnings topped Wall Street's estimates, but the company's revenue missed expectations, as drink and snack demand fell in North America.CNBC - 1d -
PayPal reports fourth-quarter earnings beat as growth picks up at Venmo
PayPal reported better-than-expected fourth-quarter earnings and revenue in its quarterly report on Tuesday.CNBC - 1d -
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.CNBC - 1d -
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.
Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results.MarketWatch - 2d -
One Palantir bear waves a white flag after earnings beat. Many remain.
Morgan Stanley has finally conceded that Palantir Technologies is not a stock to sell, but its analysts aren’t quite ready to call it a buy either.MarketWatch - 2d -
PayPal posts an earnings beat, but another metric is weighing on its stock
PayPal’s stock is down 6%, with an analyst noting that growth in branded-checkout volume seems to have trailed buy-side expectations.MarketWatch - 2d -
Palantir’s stock surges as AI traction drives huge earnings beats across the board
Palantir bet on software that allows companies to deploy large-language models in a practical sense, and management says that’s paying off big time.MarketWatch - 2d -
Tyson Foods’ chicken business powers earnings beat as stock rises
Tyson called the chicken results “exceptional.”MarketWatch - 3d -
Brown takes on Princeton following Lilly's 34-point game
Brown plays the Princeton Tigers after Kino Lilly Jr. scored 34 points in the Bears' 88-79 win against the Pennsylvania QuakersABC News - 5d -
Lilly scores 34, Brown beats Pennsylvania 88-79
The Brown Bears defeated the Pennsylvania Quakers 88-79 on Friday night led by Kino Lilly Jr.'s 34 pointsABC News - 5d -
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week.CNBC - 5d -
Apple reports sagging iPhone sales in China as first-quarter earnings barely beat Wall Street’s expectations
Investors pay close attention to tech company’s foray into AI after Apple Intelligence’s glitches and inaccuracies. Apple slightly beat analysts’ expectations in its first-quarter earnings for ...The Guardian - 6d -
Zuckerberg hails Trump administration on Meta earnings call
Meta CEO Mark Zuckerberg on Wednesday praised President Trump’s administration and said he looks forward to “redefining” the relationship the tech giant has with governments. “This is also going to ...The Hill - Jan. 30 -
Microsoft delivers an earnings beat but misses where it matters most
Investors want to see faster cloud revenue growth to justify the billions of dollars the company is investing to scale AI and Microsoft simply did not deliver.CNBC - Jan. 30 -
IBM shares rise 9% on earnings beat
In a statement, IBM CEO Arvind Krishna said the company has recorded $5 billion in bookings for its generative AI business.CNBC - Jan. 29 -
Levi beats earnings estimates but expects pressure this year from strong U.S. dollar
Levi expects its sales to slow in the current fiscal year because of the strong U.S. dollar and one fewer selling week.CNBC - Jan. 29 -
T-Mobile’s stock climbs after fourth-quarter earnings beat and robust guidance
T-Mobile expects postpaid net customer additions of between 5.5 million and 6 million for 2025, the company’s highest-ever guidance range issued at the beginning of the year.MarketWatch - Jan. 29 -
GM stock falls even as company beats analyst expectations on earnings
While investors will be watching GM's quarterly results, they will also be focused on its guidance for 2025 and any changes under the Trump administration.CNBC - Jan. 28 -
DeepSeek sets stage for frenetic tech earnings season
The sudden emergence of China's DeepSeek roiled the tech market just ahead of earnings season, when industry giants will update investors on their AI spending.CNBC - Jan. 28 -
Travelers withstands higher catastrophe losses as underwriting fuels earnings beat
Travelers Cos. executives confirm the Los Angeles wildfires will have a material impact on the insurer’s first-quarter earnings but say it’s too soon to specify the costs.MarketWatch - Jan. 22 -
Procter & Gamble earnings beat estimates as shoppers buy more household staples
Procter & Gamble beat quarterly earnings and revenue estimates and also reiterated its fiscal 2025 forecast.CNBC - Jan. 22 -
P&G didn’t raise prices for first time in 6 years, and Q2 earnings still beat
P&G’s stock powers up as profit and revenue rise above expectations, and the full-year outlook was affirmed.MarketWatch - Jan. 22 -
These hedge-fund legends beat their peers. But a simple model beat them.
The top 20 hedge funds of all time outperformed their rivals last year. But they still trailed a simple 60/40 model that is far less expensive.MarketWatch - Jan. 21 -
Trump into Masters semis and sets earnings record
World number one Judd Trump will play world champion Kyren Wilson in the last four of the Masters after beating Ding Junhui.BBC News - Jan. 17 -
How to earn $500 with a CD in 2025
Earning hundreds of dollars with a CD account is relatively simple right now. Here's how to do it this year.CBS News - Jan. 17 -
Wells Fargo shares jump after earnings beat, strong 2025 guidance
The lender expects 2025 net interest income, a key measure of what a bank makes on lending, to be 1% to 3% higher than 2024's number of $47.7 billion.CNBC - Jan. 15 -
Everything to Know About Big Banks Earnings
Goldman Sachs, JPMorgan, Wells Fargo and other firms are expected to report strong earnings.Inc. - Jan. 15 -
Allen and Trump earn stylish wins in Masters openers
Former Masters champions Mark Allen and Judd Trump win their first-round matches to reach the quarter-finals at Alexandra Palace.BBC News - Jan. 14 -
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - Jan. 13 -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - Jan. 13 -
-
Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs
Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.CNBC - Jan. 10 -
Ashford strike earns Cardiff win at Sheffield United
Cardiff City forward Cian Ashford's 19th-minute striker was enough to earn his side a 1-0 win over Sheffield United in their FA Cup third round match at Bramall Lane.BBC News - Jan. 9 -
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.CNBC - Jan. 9 -
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.MarketWatch - Jan. 9 -
Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly has been one of the worst-performing Club stocks over the past six months.CNBC - Jan. 8
